Novo Nordisk AGM re-elects Lars Rebien Sørensen as chair

At the annual general meeting on 26 March 2026, shareholders re-elected Lars Rebien Sørensen as board chair and Cees de Jong as vice chair. Helena Saxon, Jan van de Winkel and Ramona Sequeira joined the board. Board continuity matters less to the stock than pricing and pipeline news, but it confirms the leadership that oversaw the guidance reset.

• Lars Rebien Sørensen re-elected chair
• Cees de Jong re-elected vice chair
• New board members: Helena Saxon, Jan van de Winkel, Ramona Sequeira
• Hybrid meeting held in Bagsværd, Denmark